Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma

Clinical trials have demonstrated promising outcomes for adjuvant immunotherapy in patients with resected melanoma. Real-life data provide valuable insights to support patient guidance and treatment decisions.

Source: European Journal of Cancer - March 17, 2024 Category: Cancer & Oncology Authors: Rikke B. Holmstroem, Sidsel Pedersen, Rebecca Jurlander, Kasper Madsen, Marco Donia, Christina H. Ruhlmann, Henrik Schmidt, Charlotte A. Haslund, Lars Bastholt, Inge Marie Svane, Eva Ellebaek Tags: Original Research Source Type: research